Fluoroquinolone (FQ) antimicrobial agents are used extensively in human and veterinary medicine. Widespread use of any antimicrobial agent can apply selective pressure on populations of bacteria, which may result in an increase in the prevalence of antimicrobial-resistant isolates. Antimicrobial-susceptibility data on bacteria isolated from the canine urinary tract by the University of Missouri-Columbia Veterinary Medical Diagnostic Laboratory, Columbia, MO, were used to determine whether there has been an increase in the prevalence of FQ-resistant bacteria over time. Between January 1992 and December 2001, minimum inhibitory concentrations of either ciprofloxacin (1992)(1993)(1994)(1995)(1996)(1997)(1998) or enrofloxacin (1998)(1999)(2000)(2001) were determined for 1,478 bacterial isolates from the canine urinary tract. The predominant bacterial species isolated were Escherichia coli (547 isolates), Proteus mirabilis (156), and Staphylococcus intermedius (147). In all, there were 13 bacterial species with more than 25 isolates each. A significant increase in the overall proportion of resistant bacterial isolates was documented from 1992 to 2001 (Cochran-Armitage test for trend, P Ͻ 0.0001). The same increase in resistant isolates was documented when either ciprofloxacin or enrofloxacin was analyzed separately (P Ͻ 0.0001 and P Ͻ 0.0002, respectively). No difference was detected in rates of bacterial FQ resistance with regard to the sex of the dog from which the bacteria were isolated. The frequency with which some bacterial species were isolated differed with the sex of the infected dog. Proteus mirabilis was found more often in females (P Ͻ 0.0001), whereas beta hemolytic Streptococcus spp., were found more often in males (P ϭ 0.0003). Although the overall efficacy of FQ antimicrobials remained high with greater than 80% of isolates being susceptible, the data demonstrated an increase in the proportion of resistant bacteria isolated from the urinary tract of the dog.
Fluoroquinolone (FQ) antimicrobial agents function by inhibiting bacterial DNA gyrase, and they are commonly used to treat a variety of bacterial infections in dogs. As broad-spectrum bactericidal antimicrobials, FQ are effective against many gram-negative and gram-positive aerobes but possess little activity against anaerobic bacteria. Fluoroquinolones are particularly effective in treating urinary tract infections (UTI) because of the high drug concentrations attained within the urinary tract. 19 In 1988, enrofloxacin became the first FQ to be marketed for veterinary use. Shortly before the introduction of enrofloxacin, ciprofloxacin was introduced for use in humans. Enrofloxacin and ciprofloxacin are structurally and functionally very similar, and in fact, ciprofloxacin is a metabolite of enrofloxacin. 6 Because of their efficacy and relative safety, FQ rapidly gained widespread use in veterinary medicine. Simultaneously, there has been a dramatic increase in FQ use in human medicine. 4, 18, 21 Whereas there have been few such veterinary studies, several investigators have documented the development of bacterial resistance as- sociated with the growing use of FQ in human medicine. 4 For FQ to maintain an appropriate position in the antimicrobial armamentarium of practicing veterinarians, it is important to recognize the development of FQ resistance among bacterial isolates associated with disease.
The purpose of this study was to determine if there has been a change in documented FQ resistance among pathogens cultured from the canine urinary tract at the University of Missouri-Columbia Veterinary Medical Diagnostic Lab (UMC-VMDL), Columbia, MO. Additionally, the effects of sex on the pattern of resistance as well as the relationship between sex and the specific pathogens isolated from the urinary tract were examined.
Materials and methods
Bacterial isolates. Susceptibility results of urinary tract cultures submitted to the UMC-VMDL between January 1992 and December 2001 were analyzed. A vast majority of urine samples were obtained by cystocentesis, with nearly all the remaining samples collected by aseptic catheterization. Urine samples were cultured using loops calibrated to deliver 10 and 100 l samples to 5% trypticase soy sheep blood agar (SBA) a and MacConkey agar plates. a,20 A portion of each urine sample obtained by cystocentesis was filtered with a sterile 0.22-m filter, and the filter was cultured aerobically to detect samples with a low bacterial colony form-ing unit (CFU) count. To detect anaerobes, 100 l of urine was inoculated on prereduced SBA plates. a They were incubated at 35 C for 24-72 hr in a gas pak jar containing an anaerobic gas-generating system b sachet and an anaerobic indicator. All aerobic plates were incubated at 35 C for 24-48 hr. The CFU count was noted, and gram-positive isolates were identified using standard methods. 20 Gram-negative isolates were identified with an automated system. c,14 Information obtained from each urine sample identified in this search included organism(s) isolated, FQ susceptibility or resistance as determined by the minimum inhibitory concentration (MIC) of the antimicrobial, and sex of the infected dog.
Fluoroquinolone antimicrobials. During various periods of the study, either ciprofloxacin or enrofloxacin was used as the representative FQ antimicrobial for microbial-susceptibility testing. Before 1998, ciprofloxacin was used for routine FQ-susceptibility testing at the UMC-VMDL. Consequently, the majority of susceptibility data obtained before 1998 report susceptibility to ciprofloxacin rather than to enrofloxacin. Susceptibility tests run after March 1998 used enrofloxacin as the standard representative FQ antimicrobial.
Susceptibility testing. The MIC for each bacterial isolate was determined using commercially prepared lyophilized antimicrobial susceptibility trays. d Gram-negative bacterial isolates were picked to sterile, demineralized water adjusted to a 0.5 MacFarland standard for use with the AP-80 Gram Negative Identification System. c,d Ten (10 l) of the adjusted growth were transferred to 10 ml of Mueller-Hinton broth supplemented with Ca ϩϩ , Mg ϩϩ , and TES buffer. d Using an automated device, c lyophilized trays d were inoculated with 50 l per well of the broth solution, sealed with plastic tape, and incubated at 35 C for 18 hr. Gram-positive isolates were cultured in trypticase soy broth a adjusted to 0.5 MacFarland standard and incubated in a similar manner. Fastidious isolates were cultured in Mueller-Hinton broth supplemented with 0.01% sterile, lysed horse blood. Antimicrobial susceptibility trays were processed with an automated read-incubation system e or read manually. f The MIC was determined to be the least amount of antimicrobial agent required to inhibit bacterial growth. Although the high and low range of antimicrobial concentrations contained in the wells of the lyophilized trays varied somewhat during the time span examined, ciprofloxacin was most often tested with doubling dilutions of 0.06-8.0 g/ml, and enrofloxacin was tested using doubling dilutions of 0.5-4.0 g/ml. Minimum inhibitory concentrations of 2 and 1 g/ml for ciprofloxacin and enrofloxacin, respectively, were used as interpretive breakpoints to determine resistance or susceptibility based on standards set by the National Committee for Clinical Laboratory Standards. 10 Thus, an MIC below the breakpoint identified susceptible bacteria, whereas values above the breakpoints identified resistant organisms. Organisms with an MIC at the breakpoint were classified as having intermediate susceptibility. For purposes of analysis, organisms with intermediate susceptibility were grouped with resistant organisms. 8 Statistical analysis. Trends in the proportion of susceptible isolates over time were examined to identify the development of FQ resistance. Because of the large number of statistical tests conducted, a stringent P value of 0.01 was used to compensate for the increased chance of statistical error.
A 1-sided Cochran-Armitage (CA) test for trend was used to determine whether there was an increasing trend in the proportion of resistant isolates over time, ignoring the variables of antimicrobial agent and organism. For each year, the total number of FQ-resistant isolates was compared with the total number of isolates identified that year to calculate the proportion of FQ-resistant bacteria before the application of the CA test for trend. Additionally, each antimicrobial (ciprofloxacin and enrofloxacin) was analyzed in a similar manner to determine whether there was an increasing trend in the proportion of isolates resistant to each drug. The Cochran-Mantel-Haenszel (CMH) test was also used for a stratified analysis, with strata being the type of drug used.
Each of the 13 bacterial species isolated from more than 25 urine cultures was analyzed separately to determine whether there was a change in FQ resistance over time for that organism. The CA test for trend was used (as above) to determine the trend in resistance to ciprofloxacin and enrofloxacin for each of the 13 organisms. The CMH test was then used to control for the type of drug, accounting for both antimicrobial agents throughout the study period.
Chi-square test was used to determine whether there was a difference in resistance to FQ between the sex categories (female intact [FI], female spayed [FS], male intact [MI], male neutered [MN]); the CMH was then used to stratify results for year and organism. In addition, the chi-square test was used to determine whether differences in prevalence of a given bacterial isolate from each sex category were significant.
Results
Bacterial isolates. A total of 1,478 urinary bacterial isolates with available susceptibility data were identified during the study period from the computerized records search. A new computer system was integrated into the UMC-VMDL in November 1992. Because of the transition from one database system to another, some data remained inaccessible, resulting in fewer isolates reported from the first years of the study than from recent years. Ages of dogs with positive urine cultures ranged from 1 month to 20 years, with a mean of 6.9 years.
In this study, the majority of isolates in urine were of Escherichia coli (547), Proteus mirabilis (156), or Staphylococcus intermedius (147). In total, 13 bacterial agents were identified from 25 or more urine cultures ( Fig. 1) .
Susceptibility to FQ. The overall proportion of FQresistant isolates increased significantly from 1992 to 2001 (CA Trend Test, P Ͻ 0.0001, n ϭ 1,478) (Fig.  2) ; the trend toward a significant increase in resistance continued when each representative FQ was tested separately ( Fig. 3) . For the 695 isolates assayed for ciprofloxacin susceptibility or resistance, the increase in resistance was significant (P Ͻ 0.0001), as it was for the 783 isolates tested against enrofloxacin (P ϭ 0.0002). In addition, when controlling for both the type of antimicrobial and organism with the CMH statistic, the increase in resistance was again significant (P Ͻ 0.0001).
Susceptibility of individual species isolated. Although small sample sizes limited statistical power, when analyzed individually, the only 2 species of bacterial isolates for which a significant decrease in FQ susceptibility over time was demonstrated were E. coli and alpha hemolytic Streptococcus spp. (Fig. 4) . The overall resistance of E. coli to FQ antimicrobials increased significantly over time (P Ͻ 0.0001). When analysis was done for each type of antimicrobial separately, the increased resistance of E. coli to ciprofloxacin was significant (P Ͻ 0.0001), but resistance to enrofloxacin failed to reach statistical significance (P ϭ 0.022). The resistance of alpha hemolytic Streptococcus spp. to both FQ antimicrobial agents also increased during the study period (P ϭ 0.004). When each antimicrobial was assayed separately, the increase in resistance to ciprofloxacin or enrofloxacin failed to reach significance (P ϭ 0.02 and P ϭ 0.015, respectively).
Effects of sex on bacterial isolates and microbial susceptibility. Female spayed dogs accounted for 46.5% (664 of 1,463) of all positive cultures for which sex was recorded, which was more than that of any other sex category. Female intact dogs accounted for 18.4% of positive cultures, MI dogs accounted for 16.3%, and MC dogs for 21.4%. No statistically significant relationship between sex and resistance of urinary bacterial isolates to FQ antimicrobials was identified.
Two bacterial species were isolated with significantly different frequencies between sex categories. In particular, P. mirabilis infection was more prevalent in females (P Ͻ 0.0001), whereas beta hemolytic Streptococcus spp. infection was more prevalent in males (P ϭ 0.0003). Proteus mirabilis represented 10.6% of all bacterial isolates from the urinary tract of dogs but was responsible for 12.8% of isolates from FS dogs and 16.8% of isolates from FI dogs. In contrast, P. mirabilis was isolated from only 7.3% of all positive urine cultures from MI dogs and from 3.0% of cultures from MC dogs. Beta hemolytic Streptococcus spp. represented only 2.5% of the total isolates from the canine urinary tract, but it accounted for 3.0% of infections in MI dogs and for 5.9% in MC dogs, while accounting for only 1.2% of infections in both FS and FI dogs.
Discussion
The data demonstrate an increase in FQ resistance of canine urinary tract pathogens assayed by the UMC-VMDL from 1992 to 2001. These results are consistent with a slowly developing, progressive resistance to FQ, as noted by other investigators. 4, 8, 23 Re- sistance to FQ antimicrobials occurs through 2 chromosomally mediated mechanisms-alteration in FQ target sites (DNA gyrase, topoisomerase IV) and decreased intracellular drug accumulation. 1, 11, 12, [15] [16] [17] Unlike plasmid-mediated resistance, chromosomally mediated changes in susceptibility arise through mutations in bacterial DNA. Therefore, once resistance develops, the changes are irreversible and may progress to a permanent loss of therapeutic options for a given bacterial isolate. 5 Furthermore, resistance is vertically transmitted to all daughter cells of the resistant isolate, potentially leading to large populations of resistant bacteria. In contrast, horizontally transmitted plasmidmediated resistance is not permanent, often subsiding after the removal of the antimicrobial agent. 5 The retrospective nature of this study limited it to the evaluation of MIC concentrations routinely used for susceptibility testing. Detection of an increased resistance to an antimicrobial agent and detection of a decreased susceptibility to that agent are distinctly different propositions. 23 Although the methods used were adequate to detect an increase in FQ resistance, they were not adequate to detect a decrease in FQ susceptibility. Decreased susceptibility is detected by documenting increases in MIC concentrations, particularly modal MIC as well as geometric mean MIC, MIC 50 and MIC 90 . Most such incremental changes in susceptibility would occur at dilutions of antimicrobial agents that are several fold below the breakpoint MIC for that drug. Because the lowest concentration of enrofloxacin used in susceptibility testing in this study was 0.5 g/ ml, only 1 dilution less than the breakpoint MIC, changes over an appropriate range of dilutions could not be examined. More than 80% of the urinary isolates were susceptible to enrofloxacin or ciprofloxacin, with MICs less than or equal to 1 and 2 g/ml, respectively. It is likely that changes in susceptibility that were more dramatic than changes in resistance were not detected because of the limited range of drug concentrations used for routine susceptibility testing. In fact, for ciprofloxacin, the range began at 0.06 g/ ml, and the authors were able to detect increases in geometric mean MIC as well as in MIC 50 and MIC 90 each year from 1993 to 1997 (data not shown). Susceptibility changes may have occurred in a large portion of the isolates, but they remained undetected because they occurred below the ranges used in the antimicrobial-susceptibility testing.
There was an increase in resistance to FQ in urinary tract pathogens over all isolates, but when each isolate was analyzed individually, only E. coli and alpha hemolytic Streptococcus spp. demonstrated a significant increase in resistance. Each of these organisms was found in relatively high numbers, ranking first and sixth in overall prevalence. For bacterial species isolated less frequently, statistical power of analysis was limited. This numerical limitation might prevent detection of biologically relevant changes in resistance for those organisms. Alternatively, organisms with an exquisite initial susceptibility to FQ antimicrobial agents may experience a decrease in FQ susceptibility without an increase in resistance, and this trend could not be recognized by the methods used in this study.
In fact, others have demonstrated such a phenomenon among canine pathogens. 23 Development of bacterial resistance to commonly used antimicrobial agents is an expected phenomenon because bacterial mutations give rise to resistant bacterial populations through natural mutation or through plasmid-mediated transfer of resistance. An increase in FQ resistance of bacterial pathogens, as was demonstrated in this study, has been similarly demonstrated in other veterinary and human studies. Increases in resistance or decreases in susceptibility, or both, to enrofloxacin among E. coli and other canine pathogenic bacteria, including P. mirabilis, S. intermedius, and Klebsiella pneumoniae, have been clearly demonstrat-ed. 23 Increased enrofloxacin resistance of E. coli isolates from the urinary tract of dogs at the University of California VMTH Davis, California, was likely caused by a general increase in enrofloxacin resistance among uropathogenic E. coli in dogs rather than from a single hospital strain clone of E. coli. 2 Animal species other than dogs have likewise been found to harbor increasing proportions of FQ-resistant pathogens since the introduction of FQ to their therapeutic armamentarium. 9 Numerous studies of human pathogens provide evidence supporting the development of FQ resistance. 3, 4, 8, 9, 18, 21, 22 Data from a large-scale study conducted in the Netherlands showed that increased frequency of FQ prescriptions could be correlated with increased resistance of urinary tract pathogens to FQ (from 1.3% in 1989 to 5.8% in 1998). 4 The role of sex was explored with regard to FQ resistance and bacterial species isolated. Urinary tract infections in men are more likely to be resistant to antimicrobial agents than are UTI in women, probably because infection in men is often associated with defective protective mechanisms and repeated antimicrobial treatment courses. 4 As has been previously described, a higher incidence of UTI in female than in male dogs was documented in this study. 7, 19 In contrast to the case with human UTI, there was no difference in FQ susceptibility of pathogens found between sex categories for canine UTI. Although not a primary objective of this study, significant sex differences in the rate of infection with certain species of bacteria were demonstrated. As in previous studies, P. mirabilis was isolated from a disproportionate number of females, but this study did not confirm that Enterococcus spp. were more likely to be isolated from females than from males. 7 Additionally, this study documented an increased incidence of Streptococcus spp. beta hemolytic isolates from males compared with females. Reasons for these differences in urinary pathogens by sex remain unknown.
Although an increase in bacterial resistance was documented by this study, the efficacy of FQ antimicrobials remained high. In fact, FQ were effective against more than 80% of microbial isolates tested in vitro. This is similar to the figures from another recent veterinary study in which 87.5% of nonenteric E. coli isolates from dogs analyzed over a period of 8 years were susceptible to enrofloxacin. 13 Although this study measured susceptibility in vitro, the in vivo bactericidal activity of FQ depends on the concentration of the drug at the site of action. Because FQ are concentrated from 100-to 300-fold within the urinary tract, they may still be effective against isolates found to be resistant in vitro with a known MIC. 19 However, when the MIC exceeds the highest concentration on the susceptibility panel, alternative antimicrobial agents should be considered. Although this study only examined changes in FQ resistance among urinary tract pathogens, most of the same bacterial species can be found as canine pathogens in sites other than the urinary tract. It is incumbent on veterinarians to be cognizant of the role antimicrobial agents play in the development of resistant bacterial strains and to limit use of FQ in a judicious manner to maintain antimicrobial potency.
